Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn

Written by | 12 May 2023

Most antidepressants used for chronic pain are being prescribed with “insufficient” evidence of their effectiveness, scientists have warned. A major investigation into medications used to manage long-term pain… read more.

Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression

Written by | 9 Mar 2023

Aripiprazole originally was approved by the FDA in 2002 as a treatment for schizophrenia but also has been used in lower doses as an add-on treatment for clinical… read more.

Antidepressant use during pregnancy not linked to epilepsy in children

Written by | 14 May 2022

A new study suggests that antidepressant use by mothers during the first trimester of pregnancy does not increase the chances of epilepsy and seizures in babies. The research… read more.

Antidepressant prescribing during covid-19

Written by | 2 Jul 2021

Interview and article by Christine Clark. Some four million extra prescriptions for antidepressants were issued in 2020 compared to 2019 but the cost to the NHS increased by… read more.

Antidepressant therapy not significantly effective for back and osteoarthritis pain

Written by | 21 Jan 2021

Article written by Bruce Sylvester Antidepressants do not appear to provide significant back or osteoarthritis pain relief, even though they are widely prescribed for such purposes, researchers reported… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.